Companies / Japan
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Zydus Cadila Acquires Nippon Universal Pharmaceutical
April 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
In an effort to penetrate the under-developed Japanese generics market, Indian firm Zydus Cadila has bought local player Nippon Universal Pharmaceutical. While a prescient move in our opinion, we believe the small-scale nature of the transaction and the languid nature of the pharmaceutical market in Japan means upside for Zydus Cadila will be modest and take some time to be realised.